Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients

Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls

Ingrid E. Lundberg, Joan M. Brengman, Andrew G. Engel · Journal of Neuroimmunology · 1995 · 193 citations

Medicine, Immunology, Physiology +14

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

Chester V. Oddis, Lisa G. Rider, Ann M. Reed et al. · Arthritis & Rheumatism · 2005 · 186 citations

Medicine, Dermatology, Internal Medicine +13

Cytokine Expression Profile in Idiopathic Inflammatory Myopathies

Dominique S. Tews, H. H. Goebel · Journal of Neuropathology & Experimental Neurology · 1996 · 183 citations · Full text

Medicine, Immunology, Pathology +17

Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations

G.J.D. Hengstman, F.H.J. van den Hoogen, Pilar Barrera et al. · European Neurology · 2003 · 157 citations

Medicine, Immunology, Pharmacotherapy +17

ELEVATED SERUM LEVELS OF INTERLEUKIN‐1 RECEPTOR ANTAGONIST IN POLYMYOSITIS/DERMATOMYOSITIS. A Biologic Marker of Disease Activity with a Possible Role in the Lack of Acute‐Phase Protein Response

Cem Gabay, Fabienne Gay‐Croisier, Pascale Roux‐Lombard et al. · Arthritis & Rheumatism · 1994 · 101 citations

Veterinary Medicine, Immunology, Pathobiology +17